|
TCMBANKIN005327 |
phenethylrutinoside |
|
C20H30O10 |
430.4 g/mol |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OCCC3=CC=CC=C3)O)O)O)O)O)O |
|
TCMBANKIN016405 |
3,3',4-tri-O-methylellagic acid |
3,3', 4-tri-o-methylellagic acid; 3,3',4-tri-o-methylellagic acid; 3,3',4-tri-o-methyl ellagicacid; 3,3',4-tri-o-methyl ellagic acid |
|
346.31 |
|
|
TCMBANKIN039489 |
Icariside D1 |
|
|
416 |
|
|
TCMBANKIN040182 |
Coniferyl 9-O-[β-D-apiofuranosyl(1→6)]-O-β-D-glucopyranoside |
|
|
|
|
|
TCMBANKIN042281 |
3,3'-Di-O-methylellagic acid |
2239-88-5; 124590-36-9; ZINC01280637; (1)Benzopyrano(5,4,3-cde)(1)benzopyran-5,10-dione, 2,7-dihydroxy-3,8-dimethoxy-; Oprea1_264874; 3,3'-di-O-methylellagic acid; 3,3'-di-o-methylellagicacid |
|
330.25 |
|
|
TCMBANKIN044520 |
sinapyl 9-o-[β-d-apiofuranosyl(1→6)]-o-β-d-glucopyranoside |
|
C22H32O13 |
|
|
|
TCMBANKIN060693 |
Sitogluside |
|
C35H60O6 |
576.85g/mol |
CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C |
|
TCMBANKIN016143 |
3,4-O-isopropylidene shikimic acid |
|
C10H14O5 |
214.21 g/mol |
CC1(OC2C=C(CC(C2O1)O)C(=O)O)C |
|
TCMBANKIN028509 |
diellagicacidrhamnoside(1→4)glucopyrano-side |
|
C40H30O24 |
|
|
|
TCMBANKIN034273 |
5-O-Galloylquinic acid |
|
C14H16O10 |
344.27 g/mol |
C1C(C(C(CC1(C(=O)O)O)OC(=O)C2=CC(=C(C(=C2)O)O)O)O)O |
|
TCMBANKIN060152 |
3-o-methylellagicacid4-o-α-l-rhamnopyranoside |
|
C21H18O12 |
|
CC1C(C(C(C(O1)OC2=C(C3=C4C(=C2)C(=O)OC5=C4C(=CC(=C5OC)O)C(=O)O3)O)O)O)O |
|
TCMBANKIN001384 |
isopenniclavine |
Isopenniclavin; 9,10-Didehydro-8-hydroxy-6-methylergoline-8-methanol (8beta)-; UNII-957F5HGG0I; Ergoline-8alpha-methanol, 9,10-dihydro-8-hydroxy-6-methyl-; 478-92-2; 957F5HGG0I; Isopenniclavine; Ergoline-8-methanol, 9,10-didehydro-8-hydroxy-6-methyl-, (8beta)- |
C16H18N2O2 |
270.33 g/mol |
CN1CC(C=C2C1CC3=CNC4=CC=CC2=C34)(CO)O |
|
TCMBANKIN015154 |
glycerol sinapate |
Glycerol trisinapate; AC1NSVZC; Glycerol tris[3-(4-hydroxy-3,5-dimethoxyphenyl)propenoate]; 1,3-bis({[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]oxy})propan-2-yl (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate; Tri-O-sinapoylglycerol; 2,3-bis[[(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]oxy]propyl (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate |
C14H18O7 |
298.29 g/mol |
COC1=CC(=CC(=C1O)OC)C=CC(=O)OCC(CO)O |
|
TCMBANKIN019860 |
1-Methyl-3-isopropoxy cyclohexane |
SCHEMBL8295326; 1-methyl-3-propan-2-yloxycyclohexane; 1-methyl-3-isopropoxy cyclohexane; AC1NSYGG |
C10H20O |
156.26 g/mol |
CC1CCCC(C1)OC(C)C |
|
TCMBANKIN020711 |
pelletierine |
Pelletierine, (+)-; AKOS006348100; Pelletierine, (S)-(+)-; 2-Propanone, 1-(2S)-2-piperidinyl-; (S)-2-Acetonylpiperidin; (+)-Pelletierine; UNII-ES1TAU75N3; UNII-NPL21M0A40 component JEIZLWNUBXHADF-QMMMGPOBSA-N; AJ-08055; ES1TAU75N3; 2858-67-5; ZINC1592 |
C8H15NO |
141.21 g/mol |
CC(=O)CC1CCCCN1 |
|
TCMBANKIN031607 |
Pelargonidin-3,5-diglucoside |
pelargonidin-3,5-diglucoside |
C27H31ClO15 |
631 g/mol |
C1=CC(=CC=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O.[Cl-] |
|
TCMBANKIN046854 |
pseudopurpurin |
Pseudopurpurin; 2-Anthracenecarboxylic acid, 9,10-dihydro-1,3,4-trihydroxy-9,10-dioxo-; Pseudopurpurine; 2-Anthracenecarboxylicacid,9,10-dihydro-1,3,4-trihydroxy-9,10-dioxo-; SCHEMBL5075855; CTK1D7829; AC1L9DDH; 1,3,4-trihydroxy-9,10-dioxoanthracene-2-carboxylic acid; C10394; CHEBI:8608; AKOS028111424; 1,3,4-trihydroxy-9,10-dioxo-anthracene-2-carboxylic acid; DTXSID30197210; 476-41-5 |
C15H8O7 |
300.22 |
c1([H])c([H])c([H])c(C(=O)c(c(O[H])c(O[H])c(C(O[H])=O)c2O[H])c2C3=O)c3c1[H] |
|
TCMBANKIN057935 |
D-sedoheptulose |
(3S,4R,5R,6R)-1,3,4,5,6,7-hexahydroxyheptan-2-one; CHEBI:16802; D-Altro-2-heptulose; D-altro-hept-2-ulose;l-galactoheptulose;d-mannoheptulose;Sedoheptulose; (3S,4R,5R,6R)-1,3,4,5,6,7-hexahydroxyheptan-2-one; D-Sedoheptulose, >=95% (TLC); ZINC8579422; altro-Heptulose; 40A0W1XJ6X; UNII-40A0W1XJ6X; AC1NUSHL; SCHEMBL119427; CHEBI:16802; D-altro-hept-2-ulose; D-Altro-2-heptulose; 3019-74-7;L-Galactoheptulos; D-Sedoheptulose, >=95% (TLC); ZINC8579422; altro-Heptulose; 40A0W1XJ6X; UNII-40A0W1XJ6X; D-Mannoheptulose; AC1NUSHL; SCHEMBL119427; CHEBI:16802; D-altro-hept-2-ulose; D-Altro-2-heptulose; 3019-74-7 |
C7H14O7 |
210.18 g/mol |
C(C(C(C(C(C(=O)CO)O)O)O)O)O |
|
TCMBANKIN057937 |
galactitol |
meso-galactitol;18089-21-9; EINECS 210-165-2; CHEBI:16813; D0256_SIGMA; NSC 1944; ZINC04521466; (2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexol; 40742-76-5; ZINC02034453; AI3-19423;C01507; C-25615; Sorbo; I0725; I14-60913; KB-53227; CTK8B4049; L-Iditol, >=98%; FBPFZTCFMRRESA-UNTFVMJOSA-N; AC1NUSPZ; DB-051581; 488-45-9; ANW-43765; CHEBI:18202; MolPort-003-848-134; L-Iditol; CC-29952; AKOS024258141; FT-0627851; K-9194; KS-00000XZK; WURCS=1.0/1,0/[h2121h]; SCHEMBL435775; ZINC5178945; W-202860; (2S,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol; L-Idit; MFCD00064289;dulcitol |
C6H14O6 |
182.17 g/mol |
C(C(C(C(C(CO)O)O)O)O)O |
|
TCMBANKIN058957 |
n-methylisopelletierine |
methyl isopelletierine |
C9H17NO |
155.24 g/mol |
CC(=O)CC1CCCCN1C |
|
TCMBANKIN002064 |
ethanolamine |
|
C2H8NO+ |
62.09 g/mol |
C(CO)[NH3+] |
|
TCMBANKIN021156 |
trichosanic acid |
9cis, 11trans, 13cis-conjugated linolenic acid; trichosanicacid; 9c, 11t, 13c-octadecatrienoic acid; TCA; C18:3, omega-5; 9c, 11t, 13c-CLNA; 18:3Delta9Z,11E,13Z; Punicic acid |
C2HCl3O2 |
163.38 g/mol |
C(=O)(C(Cl)(Cl)Cl)O |
|
TCMBANKIN023616 |
Purine |
purine; PURINE-RING; CHEBI:17258; 6H-Imidazo(4,5-d)pyrimidine; 9H-Purine; 3,5,7-TRIAZAINDOLE; AC-907/25014050; X 128; AIDS023033; 120-73-0; EINECS 204-421-2; C00465; P55805_ALDRICH; C15587; 6H-Imidazo[4,5-d]pyrimidine; 82580_FLUKA; SBB004288; InChI=1/C5H4N4/c1-4-5(8-2-6-1)9-3-7-4/h1-3H,(H,6,7,8,9; ZINC00152268; 7H-Imidazo[4,5-d]pyrimidine; CHEBI:35589; .beta.-Purine; AI3-50208; 3H-purine; AIDS-023033; NSC 753; 1H-Purine; P1655_SIGMA; Imidazo[4,5-d]pyrimidine; 7H-Purine; NSC753; CHEBI:35586; 1H-Purine (9CI); 9H-Purine (VAN); Imidazo(4,5-d)pyrimidine; CHEBI:35588; Isopurine; beta-Purine; 7H-Imidazo(4,5-d)pyrimidine; WLN: T56 BM DN FN HNJ |
C5H4N4 |
120.11 |
C1=C2C(=NC=N1)N=CN2 |
|
TCMBANKIN058556 |
punicafolin |
|
C41H30O26 |
938.66 |
C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O1)O)O)O)O)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O |
|
TCMBANKIN058060 |
gallic acid |
Spectrum4_001544; NSC-755825; 4CN-0954; KBio2_000822; NCGC00260064-01; KBio3_001168; CHEBI:30778; GTPL5549; D0Y3TZ; NCGC00091125-01; 632XD903SP; ARONIS23903; Spectrum5_000108; Jsp002851; T7419; Gallic acid, puriss., 98.0%; I14-9302; NCGC00091125-07; ZINC1504; 3,4,5-trihydroxybenzoic acid (ACD/Name 4.0); KBioGR_002008; AK-65266; pyrogallol-5-carboxylate; BRD-K77345217-001-01-9; Gallicum acidum; LNTHITQWFMADLM-UHFFFAOYSA-N; KBio2_003390; EBD679760; NCGC00091125-04; AJ-08037; Gallic acid; ZB000350; BG01502846; A808977; (?)-Gallic acid; WLN: QVR CQ DQ EQ; N1830; AC1NEVA5; SBB008781; 149-91-7; GALLIC ACID ANHYDROUS; Gallic acid [NF]; KS-00000IWM; CS-8191; LS-870; C01424; KS-00004784; CHEBI:16918; SPECTRUM210369; c0006; UNII-632XD903SP; ACMC-20aku5; CTK0H5618; BIDD:ER0374; AC1Q732X; NCGC00091125-02; F1908-0156; Oprea1_087792; CG0029; DSSTox_RID_75711; Kyselina 3,4,5-trihydroxybenzoova; 3-10-00-02070 (Beilstein Handbook Reference); RP23206; NSC36997; Gallic acid, certified reference material, TraceCERT(R); AI3-16412; CCG-38670; STK298718; Tox21_202515; bmse000389; AN-15162; AB00052697_03; SR-05000001537-2; NSC-36997; 1886-EP2374526A1; 5-Carboxybenzene-1,2,3-triol; KBio2_005958; SR-05000001537-3; NCGC00091125-05; KBio1_001347; Kyselina gallova [Czech]; KSC175M1R; KBioSS_000822; HMS2091A07; gallate; CPD-183; Spectrum3_000254; 78563C7D-0E2D-4766-A8EA-670A03C78FCF; gallic acid ; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; GDE; SBI-0052184.P002; EINECS 205-749-9; CAS-149-91-7; Kyselina gallova; J3.617.291F; Benzoic acid, 3,4,5-trihydroxy-; BG00601456; DivK1c_006403; Benzoic acid,4,5-trihydroxy-; gallic acid for microelectronic industrial; BRN 2050274; Gallic acid tech.; NCGC00091125-03; Kyselina 3,4,5-trihydroxybenzoova [Czech]; Gallic acid, 97.5-102.5% (titration); gallicacid; 3,4,5-Trihydroxybenzoic acid, anhydrous; NSC674319; TR-020762; 3,4,5-tris(oxidanyl)benzoate; MCULE-1552954312; Gallic acid polymer; Pharmakon1600-00210369; BSPBio_001668; Tox21_111089; HMS1923K07; CCRIS 5523; BDBM50085536; NSC-674319; ST2404570; BB_SC-2795; AC-1206; 3,4,5-trihydroxy-Benzoic acid; Gallic Acid Hydrate; AC1L1934; RTR-020762; GALOP; Q-201146; SR-05000001537-1; DSSTox_CID_650; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; 3,4,5-Trihydroxybenzoic acid ion; GALLICACID; s4603; CHEMBL288114; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; NSC755825; G0011; AB1002218; Gallic Acid, F; MolPort-000-881-260; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; PS-8710; SC-46383; FT-0626592; BBL009937; MFCD00002510; SpecPlus_000307; 3,4,5-trihydroxy-Benzoate; SCHEMBL15012; DSSTox_GSID_20650; ST083487; SR-05000001537; 3,5-Trihydroxybenzoic acid; 3,4,5-Trihydroxybenzoate, X; Tox21_111089_1; Gallic acid (Monohydrate or Anhydrous) (3,4,5-Trih; 3,4,5-Trihydroxybenzoic acid;; Z966690556; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; BC200279; Spectrum2_000399; HY-N0523; HSDB 2117; AC1Q732Y; DTXSID0020650; 5-Trihydroxybenzoic acid; AKOS000119625; NSC 20103; Gallic acid, tech; 138-57-8; NSC-20103; AIDS-001349; gallate; CPD-183; Spectrum3_000254; KBio2_000822; Gallic acid monohydrate; AIDS-059239; KBio3_001168; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; C01424; CHEBI:30778; EINECS 205-749-9; CHEBI:16918; NCGC00091125-01; c0006; J3.617.291F; SPECTRUM210369; Benzoic acid, 3,4,5-trihydroxy-; DivK1c_006403; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; Spectrum5_000108; NCGC00091125-02; BRN 2050274; Oprea1_087792; NCGC00091125-03; 3-10-00-02070 (Beilstein Handbook Reference); SpecPlus_000307; Kyselina 3,4,5-trihydroxybenzoova [Czech]; KBioGR_002008; AI3-16412; NSC674319; pyrogallol-5-carboxylate; 3,4,5-tris(oxidanyl)benzoate; AIDS001349; KBio2_003390; Gallic acid polymer; 1886-EP2374526A1; ZB000350; Gallic acid; BSPBio_001668; KBio2_005958; AIDS059239; CCRIS 5523; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; A808977; 27645_RIEDEL; KBio1_001347; 398225_SIAL; Kyselina gallova [Czech]; WLN: QVR CQ DQ EQ; Spectrum2_000399; HSDB 2117; G7384_SIGMA; KBioSS_000822; GALOP; AC1NEVA5; SBB008781; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; NSC 20103; 3,4,5-Trihydroxybenzoic acid ion; 149-91-7; 3,4,5-trihydroxybenzoic acid; Galllic acid |
C7H6O5 |
170.12 |
C1=C(C=C(C(=C1O)O)O)C(=O)O |
|
TCMBANKIN023856 |
officinalisin |
|
C11H20O6 |
248.27 |
|
|
TCMBANKIN058948 |
PLO |
Prestwick_859; Delta5-Pregnen-3beta-ol-20-one; C01953; Pregnenolona [INN-Spanish]; Prestwick3_000546; LMST02030088; BPBio1_000651; P9129_SIGMA; 81630_FLUKA; 3beta-Hydroxy-5-pregnene-20-one; 3beta-hydroxypregn-5-ene-20-one; Prestwick0_000546; Pregn-5-en-20-one, 3beta-hydroxy-; 5-Pregnen-3-beta-ol-20-one; Prestwick1_000546; Pregn-5-en-20-one, 3beta-hydroxy- (8CI); 3beta-Hydroxy-5-pregnen-20-one; Pregnenolone (progesterone precursor); Prestwick2_000546; Pregnenolone (JAN/INN); Spectrum5_002057; 3beta-Hydroxypregn-5-en-20-one; CMC_13393; SPBio_002512; D00143; Pregn-5-en-20-one, 3-hydroxy-, (3-beta)-; Pregnenolonum [INN-Latin]; delta5-Pregnenolone; 3beta-Hydroxy-Delta5-pregnen-20-one; BSPBio_000591; CHEBI:16581; 5-Pregnen-3beta-ol-20-one; ZINC03861150; Pregn-5-en-20-one, 3-beta-hydroxy-; 3-beta-Hydroxypregn-5-en-20-one; Pregn-5-en-3beta-ol-20-one; Delta5-Pregnene-3beta-ol-20-one; PREGNENOLONE; ST5308463; (3BETA)-3-HYDROXYPREGN-5-EN-20-ONE; 5-Pregnenolone; 17beta-[1-Ketoethyl]-Delta5-androsten-3beta-ol; EINECS 205-647-4; 1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone; 145-13-1; NSC 1616; Pregn-5-ene-3beta-ol-20-one; 116907-59-6; Pregn-5-en-20-one, 3-hydroxy-, (3beta)- |
C21H32O2 |
316.5 g/mol |
CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
滇ICP备16009434号-1 |
Dai SX Lab